Johannesburg (AFP) | 17/12/2025 - 09:05:39 | S.Africa to expel seven Kenyans working on US Afrikaner applications
London (AFP) | 17/12/2025 - 08:15:36 | UK annual inflation slows more than expected to 3.2% in November
Sydney (AFP) | 17/12/2025 - 07:17:15 | Australian police charge alleged Bondi killer with terrorism, 15 murder counts
Paris (AFP) | 17/12/2025 - 07:01:09 | Global coal demand seen hitting record in 2025, then slowly decline: IEA
Manila (AFP) | 17/12/2025 - 06:58:24 | Philippines says no evidence of 'terrorist training' after Bondi gunmen's visit
Yangon (AFP) | 17/12/2025 - 05:44:36 | Myanmar junta says seeking to prosecute hundreds for election 'disruption'
Caracas (AFP) | 17/12/2025 - 03:40:01 | Venezuelan government slams US oil blockade as 'irrational'
Washington (AFP) | 17/12/2025 - 03:01:07 | After Sydney attack, Trump urges global fight against 'radical Islamic terrorism'
Washington (AFP) | 17/12/2025 - 01:07:19 | Trump says orders blockade of 'sanctioned oil tankers' in Venezuela
Sydney (AFP) | 17/12/2025 - 00:24:49 | Coffin arrives at first funeral for Bondi Beach shooting victims
Every day since October 7, AFP's team of journalists in Gaza have been risking their lives to cover a war that has shaken the world. They have all had to flee their homes, working without respite in the shadow of death in a territory they are not allowed to leave.
An aerial view on December 26, 2023 shows destroyed buildings in Beit Lahia following Israeli bombardments in the northern Gaza Strip. Mohammed Abed / AFP
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services d...
Regnology, a global leader in regulatory reporting and supervisory technology, today announces the successful closing of its acquisition of Wolters Kluwer’s Finance, Risk & Regulatory Reporting (FRR) business. This milestone reinforces Regnology’s position as the trusted partner for financial institutions and regulators worldwide, delivering smarter, faster compliance solutions at scale. Regnology is committed to ensuring business continuity for all FRR clients. With a proven track record ...
